(Q37010493)

17 August 2017

1 reference

title

The mast cell and allergic diseases: role in pathogenesis and implications for therapy. (English)

1 reference

17 August 2017

0 references

0 references

J M Brown

1

1 reference

17 August 2017

T M Wilson

series ordinal

2

1 reference

17 August 2017

D D Metcalfe

series ordinal

3

1 reference

17 August 2017

publication date

21 November 2007

1 reference

Clinical & Experimental Allergy

17 August 2017

published in

1 reference

17 August 2017

volume

38

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

4-18

1 reference

Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

The biology of Kit in disease and the application of pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Integrated signalling pathways for mast-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Mast cells: extended lifespan and lack of granule turnover under normal in vivo conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Activation of human mast cells through the high affinity IgG receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Activation of human mast cells by aggregated IgG through FcgammaRI: additive effects of C3a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Silica-directed mast cell activation is enhanced by scavenger receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

New and emerging roles for mast cells in host defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

IL-4 enhances proliferation and mediator release in mature human mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Inhibition of IgE-induced activation of human mast cells by IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Tryptase, a novel link between allergic inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Induction of human IgE synthesis in B cells by mast cells and basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Co-activation of naive CD4+ T cells and bone marrow-derived mast cells results in the development of Th2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

The extracellular deposition of mast cell products is increased in hypertrophic airways smooth muscles in allergic asthma but not in nonallergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Inflammation of bronchial smooth muscle in allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

The re-emergence of the mast cell as a pivotal cell in asthma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Mast-cell infiltration of airway smooth muscle in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

The CXCL10/CXCR3 Axis Mediates Human Lung Mast Cell Migration to Asthmatic Airway Smooth Muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

The role of the mast cell in the pathophysiology of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Human lung mast cells adhere to human airway smooth muscle, in part, via tumor suppressor in lung cancer-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Passive sensitization of human airways induces mast cell degranulation and release of tryptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Anaphylatoxin C3a receptors in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Distribution and degranulation of airway mast cells in normal and asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Interleukin-13 in asthma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Airway mucosal inflammation even in patients with newly diagnosed asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

The role of the mast cell in asthma: a reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

FcepsilonRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

The expression of stem cell factor and c-kit receptor in human asthmatic airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Stem cell factor-induced airway hyperreactivity in allergic and normal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Rat peritoneal mast cells present antigen to a PPD-specific T cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

The role of T regulatory cells in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Mast cells are essential intermediaries in regulatory T-cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Activation of human lung mast cells by monomeric immunoglobulin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Monomeric IgE enhances human mast cell chemokine production: IL-4 augments and dexamethasone suppresses the response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Inflammatory mediators in allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Two types of human mast cells that have distinct neutral protease compositions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Heterogeneity of mast cells and T cells in the nasal mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Allergen-Induced Release of Sulphidopeptide Leukotrienes (SRS-A) and LTB4in Allergic Rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Pathogenesis of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Localization of nerve growth factor and its receptors in the human nasal mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Mast cells synthesize, store, and release nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Human mast cells express functional TrkA and are a source of nerve growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Mast cells and atopic dermatitis. Stereological quantification of mast cells in atopic dermatitis and normal human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Mast cells and vasculature in atopic dermatitis--potential stimulus of neoangiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Association study of mast cell chymase polymorphisms with atopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Skin-nervous system interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Tryptase genetics and anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Anaphylactic shock depends on PI3K and eNOS-derived NO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Role of mast cell mediators in radiation injury and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Effects of gamma radiation on FcepsilonRI and TLR-mediated mast cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Pathways of anaphylaxis in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Allergic conjunctivitis: update on pathophysiology and prospects for future treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

21 January 2018

Human ocular mast cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Anti-IgE as a mast cell-stabilizing therapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Mechanisms of Antihistamines and Mast Cell Stabilizers in Ocular Allergic Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Intratracheal dosing with disodium cromoglycate inhibits late asthmatic response by attenuating eicosanoid production in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Effect of beta-agonists on inflammatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Omalizumab-induced reductions in mast cell Fce psilon RI expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

CC chemokine receptor 3 mobilizes to the surface of human mast cells and potentiates immunoglobulin E-dependent generation of interleukin 13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Ca2+ influx through CRAC channels activates cytosolic phospholipase A2, leukotriene C4 secretion, and expression of c-fos through ERK-dependent and -independent pathways in mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Resting and activation-dependent ion channels in human mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

The K+ channel iKCA1 potentiates Ca2+ influx and degranulation in human lung mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Functional KCa3.1 K+ channels are required for human lung mast cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Adenosine closes the K+ channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Dexamethasone suppresses gene expression and production of IL-13 by human mast cell line and lung mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Differential regulation of mast cell cytokines by both dexamethasone and the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Inhibition by glucocorticoids of the interleukin-1beta-enhanced expression of the mast cell growth factor SCF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Dexamethasone up-regulates the inhibitory adaptor protein Dok-1 and suppresses downstream activation of the mitogen-activated protein kinase pathway in antigen-stimulated RBL-2H3 mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Cutting edge: dexamethasone negatively regulates Syk in mast cells by up-regulating SRC-like adaptor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Dexamethasone inhibits maturation, cytokine production and Fc epsilon RI expression of human cord blood-derived mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Kinase inhibitors and airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Targeting mitogen-activated protein kinases for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Keynote review: phosphodiesterase-4 as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Mast cell tryptases and airway remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Agonists and antagonists of protease activated receptors (PARs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Inhibitors of mast cell tryptase beta as therapeutics for the treatment of asthma and inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Emerging roles of DP and CRTH2 in allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Targeting the prostaglandin D2 receptors DP and CRTH2 for treatment of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Mast-cell responses to pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

New strategies in the treatment and prevention of allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

Regulation of chymase production in human mast cell progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02886.X

10.1111/J.1365-2222.2007.02886.X

21 January 2018

Identifiers

DOI

1 reference

release_vfh3xf5jprgy5e3tgo46sj3tzi

17 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vfh3xf5jprgy5e3tgo46sj3tzi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference